Portal vein caffeine infusion enhances net hepatic glucose uptake during a glucose load in conscious dogs

Abstract

We determined whether intraportal caffeine infusion, at rates designed to create concentrations similar to that seen with normal dietary intake, would enhance net hepatic glucose uptake (NHGU) during a glucose load. Dogs (n = 15) were implanted with sampling and infusion catheters as well as flow probes >16 d before the studies. After a basal sampling period, dogs were administered a somatostatin infusion (0-150 min) as well as intraportal infusions of glucose [18 μmol/(kg · min)], basal glucagon [0.5 ng/(kg · min)], and insulin [8.3 pmol/ (kg · min)] to establish mild hyperinsulinemia. Arterial glucose was clamped at 10 mmol/L with a peripheral glucose infusion. At 80 min, either saline (Control; n = 7) or caffeine [1.5 μmol/(kg · min); n = 8] was infused into the portal vein. Arterial insulin, glucagon, norepinephrine, and glucose did not differ between groups. In dogs infused with caffeine, NHGU was significantly higher than in controls [21.2 ± 4.3 vs. 11.2 ± 1.6 μmol/(kg · min)]. Caffeine increased net hepatic lactate output compared with controls [12.5 ± 3.8 vs. 5.5 ± 1.5 μmol/(kg ·min)]. These findings indicate that physiologic circulating levels of caffeine can enhance NHGU during a glucose load, and the added glucose consumed by the liver is in part converted to lactate.